Albendavet 1,9%
Oral suspension
COMPOSITION:
Albendazole 1,9 mg
Excipient q.s. 1 ml
DESCRIPTION: Antihelminthic of the benzimidazole family. It alters the capacity of the helmints to obtain nutrients, acting on the energetic metabolism, inhibiting the fumarate-reductase enzyme that reduces glycogen, causing the parasite’s death by inanition.
INDICATIONS: Treatment of gastrointestinal and pulmonary nematodiasis produced by nematodes sensitive to Albendazole, in adults as well as in larval and egg forms. Treatment of Taenias infestation produced by Moniezia spp. Treatment of distomatosis. It is not recommended to treat acute fascioliasis caused by immature forms.
TARGET SPECIES: Sheep.
ADMINITRATION ROUTE: Oral administration, with dosing syringe.
POSOLOGY:
Nematodiasis and taenias treatment: 5 mg albendazol/kg b.w (2.5 ml ALBEKOR 1.9%/10 kg b.w) unique dose.
Fascioliasis treatment: 7.5 mg albendazol/kg b.w (4 ml ALBEKOR 1.9%/10 kg b.w) unique dose.
WITHDRAWAL PERIOD: Meat: 10 days. Milk: 4 days
SHELF-LIFE: 3 years from production date.
COMMERCIAL PRESENTATION: 1 and 5 litre flasks.